Skip to main content

Advertisement

Log in

The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Epidemiological data about antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is very limited. Until now, there has been no study about the epidemiology of AAV in Turkey. In this study, we evaluated the frequency of AAV in the northeastern part of Turkey. The general clinical features of patients diagnosed with AAV at our center within the last 10 years (2004–2014) were retrospectively recorded down. The incidence rates and the prevalence per 1,000,000 population aged ≥16 years were calculated. In addition, we evaluated the clinical features and survival rates of AAV patients. There were 30 patients with granulomatous polyangiitis (GPA), 15 with microscopic polyangiitis (MPA), and 5 with eosinophilic polyangiitis (EGPA). The overall prevalence of AAV in our region was 69.3/1,000,000 in individuals ≥16 years. Males had a similar prevalence (73.2/1,000,000) with females (65.4/1,000,000). The mean annual incidence rate was 8.1/million for all AAV. The annual incidence of AAV in females was 6.9/million; in males, it was 9.2/million. The annual incidence for GPA was calculated as 4.8/1,000,000, the incidence for MPA was 2.4/1,000,000, and the incidence for CSS was 0.8/1,000,000. Ten-year survival of patients with AAV was 65.3 %. The only independent poor prognostic factor in Cox’s multivariate analysis was advanced age at the time of diagnosis (OR 7.5, 95 % CI 10.6–526, p = 0.043). The frequency of all AAV in northwestern Turkey was similar to that in southern Europe; however, it was lower than the frequency in Northern Europe.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Gibelin A, Maldini C, Mahr A (2011) Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement. Semin Respir Crit Care Med 32:264–273

    Article  PubMed  Google Scholar 

  2. Piram M, Maldini C, Mahr A (2012) Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitides. Curr Opin Rheumatol 24:193–200

    Article  PubMed  Google Scholar 

  3. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG et al (2011) Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 50:1916–1920

    Article  Google Scholar 

  4. Cao Y, Schmitz JL, Yang J, Hogan SL, Bunch D, Hu Y et al (2011) DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol 22:1161–1167

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K et al (2006) Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. Clin J Am Soc Nephrol 1:1016–1022

    Article  PubMed  Google Scholar 

  6. Haugeberg G, Bie R, Bendvold A, Larsen AS, Johnsen V (1998) Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol 17:364–368

    Article  CAS  PubMed  Google Scholar 

  7. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99

    Article  PubMed  Google Scholar 

  8. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J (2003) The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 49(3):388–393

    Article  PubMed  Google Scholar 

  9. Gatenby PA, Lucas RM, Engelsen O, Ponsonby AL, Clements M (2009) Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 61:1417–1424

    Article  CAS  PubMed  Google Scholar 

  10. Mahr A, Guillevin L, Poissonnet M, Aymé S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51:92–99

    Article  PubMed  Google Scholar 

  11. Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337

    Article  CAS  Google Scholar 

  12. Gibson A, Stamp LK, Chapman PT, O’Donnell JL (2006) The epidemiology of Wegener’s granulomatosis and microscopic polyangiitis in a Southern Hemisphere region. Rheumatology (Oxford) 45:624–628

    Article  CAS  Google Scholar 

  13. Mahr AD, Neogi T, Merkel PA (2006) Epidemiology of Wegener’s granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 24(2 Suppl 41):S82–S91

    CAS  PubMed  Google Scholar 

  14. Scott DG, Bacon PA, Elliott PJ, Tribe CR, Wallington TB (1982) Systemic vasculitis in a district general hospital 1972–1980: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med 51:292–311

    CAS  PubMed  Google Scholar 

  15. Andrews M, Edmunds M, Campbell A, Walls J, Feehally J (1990) Systemic vasculitis in the 1980s—is there an increasing incidence of Wegener’s granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond 24:284–288

    CAS  PubMed  Google Scholar 

  16. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227

    Article  PubMed  Google Scholar 

  17. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192

    Article  CAS  PubMed  Google Scholar 

  18. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107

    Article  CAS  PubMed  Google Scholar 

  19. Fries JF, Hunder GG, Bloch DA, Michel BA, Arend WP, Calabrese LH et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33:1135–1136

    Article  CAS  PubMed  Google Scholar 

  20. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100

    Article  CAS  PubMed  Google Scholar 

  21. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P et al (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87:671–678

    CAS  PubMed  Google Scholar 

  22. Merkel PA (2012) Defining disease activity and damage in patients with small-vessel vasculitis. Cleve Clin J Med 79(Suppl 3):S11–S15

    Article  PubMed  Google Scholar 

  23. Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48:1560–1565

    Article  Google Scholar 

  24. Herlyn K, Buckert F, Gross WL, Reinhold-Keller E (2014) Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology (Oxford) 53:882–889

    Article  Google Scholar 

  25. Watts RA, Al-Taiar A, Scott DG, Macgregor AJ (2009) Prevalence and incidence of Wegener’s granulomatosis in the UK general practice research database. Arthritis Rheum 61:1412–1416

    Article  PubMed  Google Scholar 

  26. Faurschou M, Helleberg M, Obel N, Baslund B (2013) Incidence of granulomatosis with polyangiitis (Wegener’s) in Greenland and the Faroe Islands: epidemiology of an ANCA-associated vasculitic syndrome in two ethnically distinct populations in the North Atlantic area. Clin Exp Rheumatol 31(1 Suppl 75):S52–S55

    CAS  PubMed  Google Scholar 

  27. Koldingsnes W, Nossent H (2000) Epidemiology of Wegener’s granulomatosis in northern Norway. Arthritis Rheum 43:2481–2487

    Article  CAS  PubMed  Google Scholar 

  28. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA (1996) The epidemiology of Wegener’s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 39:87–92

    Article  CAS  PubMed  Google Scholar 

  29. Ormerod AS, Cook MC (2008) Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales. Intern Med J 38:816–823

    Article  CAS  PubMed  Google Scholar 

  30. Panagiotakis SH, Perysinakis GS, Kritikos H, Vassilopoulos D, Vrentzos G, Linardakis M et al (2009) The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients. Clin Exp Rheumatol 27:409–415

    CAS  PubMed  Google Scholar 

  31. Takala JH, Kautiainen H, Malmberg H, Leirisalo-Repo M (2008) Incidence of Wegener’s granulomatosis in Finland 1981–2000. Clin Exp Rheumatol 26(3 Suppl 49):S81–S85

    CAS  PubMed  Google Scholar 

  32. Dadoniene J, Kirdaite G, Mackiewicz Z, Rimkevicius A, Haugeberg G (2005) Incidence of primary systemic vasculitis in Vilnius: a university hospital population based study. Ann Rheum Dis 64(2):335–336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Hissaria P, Cai FZ, Ahern M, Smith M, Gillis D, Roberts-Thomson P (2008) Wegener’s granulomatosis: epidemiological and clinical features in a South Australian study. Intern Med J 38:776–780

    Article  CAS  PubMed  Google Scholar 

  34. Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH, Gross WL (2000) Giant cell arteritis is more prevalent in urban than rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology (Oxford) 39(12):1396–1402

    Article  CAS  Google Scholar 

  35. Cakır N, Pamuk Ö, Derviş E, Imeryüz N, Uslu H, Benian Ö et al (2012) The prevalences of some rheumatic diseases in western Turkey: Havsa study. Rheumatol Int 32:895–908

    Article  PubMed  Google Scholar 

  36. Watts RA, Lane SE, Bentham G, Scott DG (2000) Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 43:414–419

    Article  CAS  PubMed  Google Scholar 

  37. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG (2001) Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 60:170–172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Watts RA, Scott DG (1997) Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 11:191–217

    Article  CAS  PubMed  Google Scholar 

  39. Watts RA, Scott DG, Jayne DR, Ito-Ihara T, Muso E, Fujimoto S et al (2008) Renal vasculitis in Japan and the UK—are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant 23:3928–3931

    Article  PubMed  Google Scholar 

  40. Chen M, Yu F, Zhang Y, Zhao MH (2005) Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre. Postgrad Med J 81:723–727

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Li ZY, Chang DY, Zhao MH, Chen M (2014) Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a study of 439 cases in a single Chinese center. Arthritis Rheumatol 66:1920–1926

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ömer Nuri Pamuk.

Ethics declarations

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pamuk, Ö.N., Dönmez, S., Calayır, G.B. et al. The epidemiology of antineutrophil cytoplasmic antibody-associated vasculitis in northwestern Turkey. Clin Rheumatol 35, 2063–2071 (2016). https://doi.org/10.1007/s10067-016-3232-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3232-y

Keywords

Navigation